These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29415959)

  • 1. [Polymer Gel Dosimetry for the High-Dose-Rate Brachytherapy Using Ir-192 Source].
    Watanabe Y; Mizukami S; Eguchi K; Maeyama T; Hayashi SI; Terazaki T; Yamamoto K; Shuto N; Gomi T
    Igaku Butsuri; 2017; 37(3):173-176. PubMed ID: 29415959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
    Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 3D dose distributions for HDR 192Ir brachytherapy sources with normoxic polymer gel dosimetry and treatment planning system.
    Senkesen O; Tezcanli E; Buyuksarac B; Ozbay I
    Med Dosim; 2014; 39(3):266-71. PubMed ID: 24933316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry.
    Casey KE; Alvarez P; Kry SF; Howell RM; Lawyer A; Followill D
    Med Phys; 2013 Nov; 40(11):112102. PubMed ID: 24320455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verification of dose distribution in high-dose-rate brachytherapy using a nanoclay-based radio-fluorogenic gel dosimeter.
    Watanabe Y; Maeyama T; Mochizuki A; Mizukami S; Hayashi SI; Terazaki T; Muraishi H; Takei H; Gomi T; Shimono T
    Phys Med Biol; 2020 Aug; 65(17):175008. PubMed ID: 32485693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suitability of microDiamond detectors for the determination of absorbed dose to water around high-dose-rate
    Kaveckyte V; Malusek A; Benmakhlouf H; Alm Carlsson G; Carlsson Tedgren Å
    Med Phys; 2018 Jan; 45(1):429-437. PubMed ID: 29171060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-to-end delivery quality assurance of computed tomography-based high-dose-rate brachytherapy using a gel dosimeter.
    Tachibana H; Watanabe Y; Mizukami S; Maeyama T; Terazaki T; Uehara R; Akimoto T
    Brachytherapy; 2020; 19(3):362-371. PubMed ID: 32209357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-to-end dosimetric audit: A novel procedure developed for Irish HDR brachytherapy centres.
    Bassi S; Berrigan L; Zuchora A; Fahy L; Moore M
    Phys Med; 2020 Dec; 80():221-229. PubMed ID: 33190078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Source position verification and dosimetry in HDR brachytherapy using an EPID.
    Smith RL; Taylor ML; McDermott LN; Haworth A; Millar JL; Franich RD
    Med Phys; 2013 Nov; 40(11):111706. PubMed ID: 24320414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorbed dose distribution measurements in brachytherapy using ferrous sulphate gel and magnetic resonance imaging.
    Olsen DR; Hellesnes J
    Br J Radiol; 1994 Nov; 67(803):1121-6. PubMed ID: 7820406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.
    Roué A; Venselaar JL; Ferreira IH; Bridier A; Van Dam J
    Radiother Oncol; 2007 Apr; 83(1):86-93. PubMed ID: 17368842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry close to an 192Ir HDR source using N-vinylpyrrolidone based polymer gels and magnetic resonance imaging.
    Papagiannis P; Pappas E; Kipouros P; Angelopoulos A; Sakelliou L; Baras P; Karaiskos P; Seimenis I; Sandilos P; Baltas D
    Med Phys; 2001 Jul; 28(7):1416-26. PubMed ID: 11488573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo dosimetry of the IRAsource high dose rate (192)Ir brachytherapy source.
    Sarabiasl A; Ayoobian N; Jabbari I; Poorbaygi H; Javanshir MR
    Australas Phys Eng Sci Med; 2016 Jun; 39(2):413-22. PubMed ID: 26906341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
    Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
    Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit on source strength determination for HDR and PDR (192)Ir brachytherapy in Sweden.
    Carlsson Tedgren A; Grindborg JE
    Radiother Oncol; 2008 Jan; 86(1):126-30. PubMed ID: 18187219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positional and angular tracking of HDR
    Aldelaijan S; Devic S; Bekerat H; Papaconstadopoulos P; Schneider J; Seuntjens J; Cormack RA; Buzurovic IM
    Med Phys; 2020 Dec; 47(12):6122-6139. PubMed ID: 33064876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dosimetry of HDR afterloading machines with Ir-192- und Co-60-sources: comparison of different international protocols].
    Zakaria GA; Schütte W; Azhari HA
    Z Med Phys; 2010; 20(3):215-24. PubMed ID: 20638254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of
    Safigholi H; Meigooni AS; Song WY
    Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.